Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Smith & Nephew SNATS Inc

SN
Current price
961 GBX +6.82 GBX (+0.71%)
Last closed 24.58 USD
ISIN US83175M2052
Sector Healthcare
Industry Medical Devices
Exchange London Exchange
Capitalization 10 786 342 912 USD
Yield for 12 month -4.09 %
1Y
3Y
5Y
10Y
15Y
SN
21.11.2021 - 28.11.2021

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Address: Building 5, Watford, United Kingdom, WD18 8YE

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

32.5 USD

P/E ratio

35.3429

Dividend Yield

3.05 %

Current Year

+5 549 000 000 USD

Last Year

+5 215 000 000 USD

Current Quarter

+2 827 000 000 USD

Last Quarter

+2 792 630 483 USD

Current Year

+3 701 000 000 USD

Last Year

+3 695 000 000 USD

Current Quarter

+1 974 000 000 USD

Last Quarter

+1 905 734 692 USD

Key Figures SN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 076 000 000 USD
Operating Margin TTM 11.6 %
PE Ratio 35.3429
Return On Assets TTM 4.51 %
PEG Ratio 0.4106
Return On Equity TTM 5.84 %
Wall Street Target Price 32.5 USD
Revenue TTM 5 641 999 872 USD
Book Value 5.96 USD
Revenue Per Share TTM
Dividend Share 0.38 USD
Quarterly Revenue Growth YOY 3.4 %
Dividend Yield 3.05 %
Gross Profit TTM 3 695 000 000 USD
Earnings per share 0.7 USD
Diluted Eps TTM 0.7 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 24.4 %
Profit Margin 5.41 %

Dividend Analytics SN

Dividend growth over 5 years

2 %

Continuous growth

Payout Ratio 5 years average

93 %

Dividend History SN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.75
Ex Dividend Date 04.10.2024
Forward Annual Dividend Yield 3.03 %
Last Split Factor 2499:1000
Payout Ratio 107.45 %
Last Split Date 15.10.2014
Dividend Date 08.11.2024

Stock Valuation SN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 35.3429
Forward PE 10.5708
Enterprise Value Revenue 2.4191
Price Sales TTM 1.9118
Enterprise Value EBITDA 13.7449
Price Book MRQ 2.0723

Financials SN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SN

For 52 weeks

23.42 USD 31.42 USD
50 Day MA 29.37 USD
Shares Short Prior Month 3 311 584
200 Day MA 27.48 USD
Short Ratio 5.03
Shares Short 2 641 850
Short Percent 0.16 %